6.52
-0.27(-3.98%)
Currency In USD
| Previous Close | 6.79 |
| Open | 6.82 |
| Day High | 7.15 |
| Day Low | 6.48 |
| 52-Week High | 14.84 |
| 52-Week Low | 5.46 |
| Volume | 315,870 |
| Average Volume | 218,317 |
| Market Cap | 257.46M |
| PE | -4.44 |
| EPS | -1.47 |
| Moving Average 50 Days | 6.5 |
| Moving Average 200 Days | 7.26 |
| Change | -0.27 |
If you invested $1000 in Pulmonx Corporation (LUNG) since IPO date, it would be worth $165.86 as of January 03, 2025 at a share price of $6.52. Whereas If you bought $1000 worth of Pulmonx Corporation (LUNG) shares 3 years ago, it would be worth $183.61 as of January 03, 2025 at a share price of $6.52.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Pulmonx to Present at the Piper Sandler 36th Annual Healthcare Conference
GlobeNewswire Inc.
Nov 20, 2024 9:05 PM GMT
REDWOOD CITY, Calif., Nov. 20, 2024 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”) a global leader in minimally invasive treatments for severe lung disease, today announced the company will be participating in a fireside chat at
Pulmonx to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
GlobeNewswire Inc.
Nov 07, 2024 9:05 PM GMT
REDWOOD CITY, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”) a global leader in minimally invasive treatments for severe lung disease, today announced the company will be participating in investor meetings
Pulmonx to Present at the Stifel 2024 Healthcare Conference
GlobeNewswire Inc.
Nov 05, 2024 9:05 PM GMT
REDWOOD CITY, Calif., Nov. 05, 2024 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”) a global leader in minimally invasive treatments for severe lung disease, today announced the company will be participating in a fireside chat at